<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>29(4)</volume><submitter>Stroeder J</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To determine a conversion factor for use when switching from dexmedetomidine infusion to enteral clonidine in critically ill neonates.&lt;h4>Methods&lt;/h4>This was an observational, retrospective review of conversions from dexmedetomidine to -clonidine, performed in a neonatal intensive care unit (NICU) between January 2020 and December 2021. Both initial conversion factors and those resulting after a 48-hour titration period were examined. Sedation and withdrawal scores were measured, and doses were titrated based on a standardized practice within the unit.&lt;h4>Results&lt;/h4>A total of 43 dexmedetomidine to clonidine conversions were included. The median (IQR) dexmedetomidine dose prior to conversion was 17.4 (11.3-24.0) mcg/kg/day (0.7 mcg/kg/hr) and the median (IQR) enteral cl</pubmed_abstract><journal>The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG</journal><pagination>375-378</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11321815</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Identification of a Conversion Factor for Dexmedetomidine to Clonidine Transitions.</pubmed_title><pmcid>PMC11321815</pmcid><pubmed_authors>Stroeder J</pubmed_authors><pubmed_authors>Dersch-Mills D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of a Conversion Factor for Dexmedetomidine to Clonidine Transitions.</name><description>&lt;h4>Objective&lt;/h4>To determine a conversion factor for use when switching from dexmedetomidine infusion to enteral clonidine in critically ill neonates.&lt;h4>Methods&lt;/h4>This was an observational, retrospective review of conversions from dexmedetomidine to -clonidine, performed in a neonatal intensive care unit (NICU) between January 2020 and December 2021. Both initial conversion factors and those resulting after a 48-hour titration period were examined. Sedation and withdrawal scores were measured, and doses were titrated based on a standardized practice within the unit.&lt;h4>Results&lt;/h4>A total of 43 dexmedetomidine to clonidine conversions were included. The median (IQR) dexmedetomidine dose prior to conversion was 17.4 (11.3-24.0) mcg/kg/day (0.7 mcg/kg/hr) and the median (IQR) enteral cl</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2025-04-04T02:20:49Z</modification><creation>2024-11-05T16:00:46.446Z</creation></dates><accession>S-EPMC11321815</accession><cross_references><pubmed>39144393</pubmed><doi>10.5863/1551-6776-29.4.375</doi></cross_references></HashMap>